Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Brain Communications
|
May 1, 2026
White matter hyperintensities, retinal vascular calibre and changes in age-related hearing loss
David P Q Clark, Cammie Tran, Sultana Monira Hussain, et al.
JAMA Network Open
|
July 25, 2024
Low-Dose Aspirin and Progression of Age-Related Hearing Loss: A Secondary Analysis of the ASPREE Randomized Clinical Trial
David P Q Clark, Zhen Zhou, Sultana M Hussain, et al.
Human Molecular Genetics
|
January 9, 2013
A new locus for X-linked dominant Charcot-Marie-Tooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene
Marina L Kennerson, Eppie M Yiu, David T Chuang, et al.
Neurology
|
January 14, 2026
Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive Decline and Dementia
Lachlan Cribb, Margarita Moreno-Betancur, Matthew Paul Pase, et al.
Neurology
|
March 20, 2026
Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive Decline and Dementia
Lachlan Cribb, Margarita Moreno-Betancur, Matthew Paul Pase, et al.
Pharmacology Research & Perspectives
|
July 5, 2024
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
Samira Anderson, Guido Cavaletti, Linda J Hood, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 3, 2025
The Effect of Treating Hearing Loss with Hearing Aids on Plasma Biomarkers of Alzheimer's Disease and Related Dementias
Lachlan Cribb, Margarita Moreno Betancur, Julia Sarant, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 26, 2026
The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer's disease and related dementias
Lachlan Cribb, Margarita Moreno-Betancur, Julia Sarant, et al.
Journal of Neurology
|
April 8, 2015
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
Eppie M Yiu, Geneieve Tai, Roger E Peverill, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Brain Communications
|
May 1, 2026
White matter hyperintensities, retinal vascular calibre and changes in age-related hearing loss
David P Q Clark, Cammie Tran, Sultana Monira Hussain, et al.
JAMA Network Open
|
July 25, 2024
Low-Dose Aspirin and Progression of Age-Related Hearing Loss: A Secondary Analysis of the ASPREE Randomized Clinical Trial
David P Q Clark, Zhen Zhou, Sultana M Hussain, et al.
Human Molecular Genetics
|
January 9, 2013
A new locus for X-linked dominant Charcot-Marie-Tooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene
Marina L Kennerson, Eppie M Yiu, David T Chuang, et al.
Neurology
|
January 14, 2026
Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive Decline and Dementia
Lachlan Cribb, Margarita Moreno-Betancur, Matthew Paul Pase, et al.
Neurology
|
March 20, 2026
Treating Hearing Loss With Hearing Aids for the Prevention of Cognitive Decline and Dementia
Lachlan Cribb, Margarita Moreno-Betancur, Matthew Paul Pase, et al.
Pharmacology Research & Perspectives
|
July 5, 2024
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
Samira Anderson, Guido Cavaletti, Linda J Hood, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 3, 2025
The Effect of Treating Hearing Loss with Hearing Aids on Plasma Biomarkers of Alzheimer's Disease and Related Dementias
Lachlan Cribb, Margarita Moreno Betancur, Julia Sarant, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 26, 2026
The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer's disease and related dementias
Lachlan Cribb, Margarita Moreno-Betancur, Julia Sarant, et al.
Journal of Neurology
|
April 8, 2015
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
Eppie M Yiu, Geneieve Tai, Roger E Peverill, et al.
Page
of 9